NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Assertio Holdings Inc (NASDAQ: ASRT)

 
ASRT Technical Analysis
5
As on 26th Dec 2025 ASRT SHARE Price closed @ 9.94 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.76 & Strong Buy for SHORT-TERM with Stoploss of 0.87 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ASRTSHARE Price

Open 9.68 Change Price %
High 10.42 1 Day 9.28 1406.06
Low 9.50 1 Week 9.21 1261.64
Close 9.94 1 Month 9.08 1055.81
Volume 129952 1 Year 8.94 894.00
52 Week High 9.94 | 52 Week Low 0.53
 
NASDAQ USA Most Active Stocks
LPTX 2.05 365.91%
AMRS 0.14 100.00%
WBA 11.98 0.50%
NVDA 190.53 1.02%
LMDX 0.02 0.00%
YGMZ 0.02 -66.67%
AKTS 0.04 0.00%
LILM 0.05 0.00%
PONO 1.72 2.38%
TELL 1.00 0.00%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
ASRT 9.94 1406.06%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
LPTX 2.05 365.91%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
 
NASDAQ USA Top Losers Stocks
XOSWW 0.00 -100.00%
TBIO 0.00 -100.00%
HTOOW 0.00 -100.00%
ARKOW 0.00 -100.00%
FPAY 0.01 -94.74%
ZIVOW 0.04 -92.73%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
SWSSU 1.06 -89.40%
OTRK 0.07 -78.79%
 
 
ASRT
Daily Charts
ASRT
Intraday Charts
Whats New @
Bazaartrend
ASRT
Free Analysis
 
ASRT Important Levels Intraday
RESISTANCE11.71
RESISTANCE11.14
RESISTANCE10.79
RESISTANCE10.44
SUPPORT9.44
SUPPORT9.09
SUPPORT8.74
SUPPORT8.17
 
ASRT Forecast December 2025
4th UP Forecast10.13
3rd UP Forecast10.07
2nd UP Forecast10.03
1st UP Forecast9.99
1st DOWN Forecast9.89
2nd DOWN Forecast9.85
3rd DOWN Forecast9.81
4th DOWN Forecast9.75
 
ASRT Weekly Forecast
4th UP Forecast10.21
3rd UP Forecast10.12
2nd UP Forecast10.07
1st UP Forecast10.02
1st DOWN Forecast9.86
2nd DOWN Forecast9.81
3rd DOWN Forecast9.76
4th DOWN Forecast9.67
 
ASRT Forecast2025
4th UP Forecast29.04
3rd UP Forecast22.91
2nd UP Forecast19.13
1st UP Forecast15.34
1st DOWN Forecast4.54
2nd DOWN Forecast0.75
3rd DOWN Forecast-3.03
4th DOWN Forecast-9.16
 
 
ASRT Other Details
Segment EQ
Market Capital 45383980.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
ASRT Address
ASRT
 
ASRT Latest News
 
Your Comments and Response on Assertio Holdings Inc
 
ASRT Business Profile
Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. The company's pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; moderate to severe ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, an NSAID for relief of mild to moderate acute pain; and SPRIX, an NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois. Address: 100 South Saunders Road, Lake Forest, IL, United States, 60045
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service